stella
beta
Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis — Stella
Home
/
EBV-associated T/NK-cell Lymphoproliferative Diseases
/
View on ClinicalTrials.gov
Recruiting
Back to EBV-associated T/NK-cell Lymphoproliferative Diseases trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Beijing Children's Hospital, Capital Medical University, Beijing, Beijing Municipality